Fluorobiotech is proud to congratulate our Chief Quality Officer, Etienne du Toit, on the successful completion of the CQI and IRCA Certified Medical Devices – Quality Management Systems Auditor/Lead Auditor Training Course (ISO 13485:2016) (PR369).
This prestigious certification highlights Etienne’s unwavering commitment to quality, compliance, and continuous improvement — values that are central to Fluorobiotech’s operations in biotechnology and recombinant enzyme production.
“Etienne’s achievement reinforces our commitment to upholding the highest international standards in quality management,” said a Fluorobiotech spokesperson. “His leadership ensures that our systems are not only compliant but forward-thinking and resilient in a rapidly evolving global health landscape.”
The ISO 13485:2016 standard is globally recognized as the benchmark for quality management systems in the medical device and life sciences industries. By completing this rigorous auditor training, Etienne brings enhanced capability to monitor, evaluate, and strengthen internal systems, ensuring that Fluorobiotech remains a leader in both product integrity and regulatory excellence.
As we continue to grow and innovate, it is this level of expertise and dedication that drives Fluorobiotech’s quality culture and our mission to deliver safe, effective, and globally trusted biotech solutions.